一种新型定量微阵列抗体捕获试验发现蒙古乙型肝炎病毒感染者中丁型肝炎病毒患病率极高
研究开发了一种高通量定量微阵列抗体捕获试验检测抗HDV IgG,该试验在蒙古随机人群的HBV感染者中筛查发现57%为HDV RNA阳性、另4%仅western blot阳性,提示HDV合并感染率约60%,可能解释蒙古肝细胞癌高发。
要点
- 新型微阵列抗体捕获试验两个定量阈值可100%预测western blot阳性或HDV RNA阳性。
- 蒙古HBV感染者中57%为HDV RNA阳性,另4%仅western blot阳性。
- 蒙古HBV感染者中HDV合并感染率约60%,可能解释当地肝细胞癌高发。
核心结论
- 该定量微阵列抗体捕获试验的性能特点使其适合人群筛查;应用于蒙古HBV表面抗原阳性人群显示HDV合并感染率约60%,可能有助于解释蒙古肝细胞癌异常高发。
研究设计与样本
- 开发高通量定量微阵列抗体捕获试验检测抗HDV免疫球蛋白G,并将重组HDV delta抗原打印在涂有非连续纳米结构等离激元金膜的载玻片上,实现小量患者血清中抗HDV抗体的定量荧光检测。
- 该试验用于筛查大型随机选择队列中所有HBV感染者,该队列旨在代表蒙古人群。
主要发现
- 确定两个捕获抗体定量阈值,对样本在标准western blot阳性或实时定量PCR可检测HDV RNA均为100%预测。
- 对HBV阳性队列后续筛查显示57%为RNA阳性,另4%仅western blot阳性。
关键数值与推荐
- 两个定量阈值对样本western blot阳性或HDV RNA阳性均为100%预测。
- HBV阳性队列中57%为HDV RNA阳性,另4%仅western blot阳性。
- 蒙古HBV感染者中HDV合并感染率约60%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hepatitis delta virus (HDV) causes the most severe form of human viral hepatitis. HDV requires a hepatitis B virus (HBV) coinfection to provide HDV with HBV surface antigen envelope proteins. The net effect of HDV is to make the underlying HBV disease worse, including higher rates of hepatocellular carcinoma. Accurate assessments of current HDV prevalence have been hampered by the lack of readily available and reliable quantitative assays, combined with the absence of a Food and Drug Administration-approved therapy. We sought to develop a convenient assay for accurately screening populations and to use this assay to determine HDV prevalence in a population with abnormally high rates of hepatocellular carcinoma. We developed a high-throughput quantitative microarray antibody capture assay for anti-HDV immunoglobulin G wherein recombinant HDV delta antigen is printed by microarray on slides coated with a noncontinuous, nanostructured plasmonic gold film, enabling quantitative fluorescent detection of anti-HDV antibody in small aliquots of patient serum. This assay was then used to screen all HBV-infected patients identified in a large randomly selected cohort designed to represent the Mongolian population. We identified two quantitative thresholds of captured antibody that were 100% predictive of the sample either being positive on standard western blot or harboring HDV RNA detectable by real-time quantitative PCR. Subsequent screening of the HBV+ cohort revealed that a remarkable 57% were RNA+ and an additional 4% were positive on western blot alone. CONCLUSION: The quantitative microarray antibody capture assay's unique performance characteristics make it ideal for population screening; its application to the Mongolian HBV surface antigen-positive population reveals an apparent ∼60% prevalence of HDV coinfection among these HBV-infected Mongolian subjects, which may help explain the extraordinarily high rate of hepatocellular carcinoma in Mongolia. (Hepatology 2017;66:1739-1749).
引用
- Chen X, Oidovsambuu O, Liu P, et al. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians. Hepatology. 2017. PMID: 27880976. doi:10.1002/hep.28957
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。